Content about Novartis

March 14, 2010
Perrigo launches generic Zaditor

Perrigo on Monday announced that it has begun shipping ketotifen fumarate ophthalmic solution, 0.025%, a...

March 3, 2010
APhA recognizes Touro College with immunization award

The American Pharmacist Association has given its Immunization Champion Award to a school of pharmacy...

NEW YORK The American Pharmacist Association has given its Immunization Champion Award to a school of pharmacy in New York City.

 

Touro College of Pharmacy, in the Harlem neighborhood, was among more than 100 nominees competing for the ward, which receives support from Novartis Vaccines & Diagnostics. The award program will take place at the APhA’s annual meeting in Washington from March 12 to 15.

 

 

February 28, 2010
Manufacturers’ Roulette unlikely to pay a second time

Banking on pandemics is a bit like betting green at the Roulette table. It doesn’t...

February 25, 2010
Colgate-Palmolive adds two members to board of directors

Colgate-Palmolive appointed Helene Gayle, president and CEO of Care USA, and Joseph Jimenez, CEO of...

February 21, 2010
FDA approves Menveo

Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the...

CAMBRIDGE, Mass. Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the Swiss drug maker’s vaccines division announced Monday.

The FDA approved Menveo (meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197) to prevent meningococcal disease caused by Neisseria meningitidis bacteria.

 

February 18, 2010
Novartis' Tasigna receives priority review from FDA

The Food and Drug Administration will shorten its review time of a Novartis drug under...

February 17, 2010
Decision Resources projects growth in targeted cancer drug market

The market for drugs that fight cancer by focusing on specific molecules, proteins and enzymes...

February 17, 2010
Novartis to change name, repackage Maalox Total Relief

Choosing the wrong liquid Maalox product can have harmful consequences, the Food and Drug Administration...

January 28, 2010
FDA tentatively approves bone cancer generic

The Food and Drug Administration has given tentative approval to a generic version of a...

January 25, 2010
Novartis' Vasella to focus on being chairman, bows out from CEO role

Daniel Vasella will step down as CEO of Novartis to focus on his position as...

January 25, 2010
Sandoz affirms its generic anti-clotting drug will be approved

Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...

January 20, 2010
Sandoz launches generic mental disorder treatment

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...

January 20, 2010
Teva receives tentative approval for breast cancer drug

The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...

January 19, 2010
Alcon criticizes Novartis' acquisition offer

Alcon has seen Novartis’ acquisition offer, and it is not impressed....

January 10, 2010
New P&G initiative may create clash of the OTC titans

This is shaping up to be a Fight Night dream card, with the battle arena...

WHAT IT MEANS AND WHY IT'S IMPORTANT This is shaping up to be a Fight Night dream card, with the battle arena located in the digestives aisle of a pharmacy near you. Are you ready to rumble?

(THE NEWS: P&G develops new program in line with Prilosec OTC. For the full story, click here)

January 10, 2010
Novartis launches Fanapt

Novartis has launched a new drug for treating schizophrenia in the United States, the Swiss...

January 3, 2010
Novartis announces merger proposal for Alcon

Novartis is looking to purchase the remaining shares in an eye care company....

January 3, 2010
Novartis announces merger proposal for Alcon

With an eye to the future, Novartis brass envisions a growth arena driven by the...

NEW YORK With an eye to the future, Novartis brass envisions a growth arena driven by the aging Boomer population — eye care, along with all of the products, medicines and surgeries associated with eye care.

December 3, 2009
Zegerid OTC approved as heartburn remedy

The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump...

NEW YORK The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump inhibitors on the shelf. And while there may be some question as to just how large sales of antacids can get, one thing is for sure: There will be a slew of advertisers vying for their own increased share of stomach.

June 28, 2009
Santarus announces Schering-Plough response submission to FDA for OTC Zegerid

There was speculation in January that Schering-Plough’s switch application around the proton-pump inhibitor Zegerid was...

NEW YORK There was speculation in January that Schering-Plough’s switch application around the proton-pump inhibitor Zegerid was scuttled after receiving a complete response letter from the Food and Drug Administration.

 

June 11, 2009
Report finds vaccines are major area of growth

The report by Kalorama Information indicating that one of the biggest areas of growth has...

NEW YORK The report by Kalorama Information indicating that one of the biggest areas of growth has been vaccines, and that the market is expected to double by 2013, is big news for the industry, as pharmacies and retail-based clinics are bound to reap the benefits.

This is especially true given the current trajectory health reform is on in this country, and the fact that clinics and pharmacies are emerging and expanding their services to help fill the “medical home” void.